ECHELON BIOSCIENCES, INC.

Basic Information

675 Arapeen Drive, Suite 302
Salt Lake City, UT, 84108-1228

Company Profile

n/a

Additional Details

Field Value
DUNS: 179151188
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Targeting ether lipid biosynthesis for disease

    Amount: $224,334.00

    DESCRIPTION (provided by applicant): Cancer is a significant health burden in the US and across the globe, representing the second leading cause of death in the US. Cancer cells have metabolic pathway ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. IGF::OT::IGF-- Biomarkers for Alcohol and ALD

    Amount: $625,360.00

    This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Busi ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. New Approach to Phospholipidosis Prediction

    Amount: $875,580.00

    DESCRIPTION provided by applicant Drug safety is a major concern for pharmaceutical groups regulatory bodies basic researchers and particularly patients Safe and effective drugs maximize success ...

    SBIR Phase II 2014 Department of Health and Human Services
  4. SBIR Phase II: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $487,812.00

    This Small Business Innovation Research (SBIR) Phase II project aims to further develop ATX-Red, an in vivo imaging agent that becomes fluorescent in the presence of the enzyme autotaxin. Autotaxin an ...

    SBIR Phase II 2012 National Science Foundation
  5. SBIR PHASE II- 1,136,508YR 1: BASE: 548,090, PARTIALLY FUNDED AT 430,000 (BALANCE TO BE FUNDED: 118,090)YR 2: OPTION: 588,418

    Amount: $548,090.00

    There needs to better biomarkers of alcohol consumption and alcohol induced organ damage. PEth is a nonoxidative, long-lasting metabolite of ethanol consumption and alcohol related organ damage. PEth ...

    SBIR Phase II 2012 Department of Health and Human Services
  6. New Approach to Phospholipidosis Prediction

    Amount: $149,884.00

    DESCRIPTION (provided by applicant): Drug safety is a major concern for people that taking medicines as well as pharmaceutical companies, regulatory bodies, and basic researchers. Drug induced phospho ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. SBIR Phase I: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to synthesize ATXRed, an in vivo imaging agent that is specifically activated by the enzymatic activity of autotaxin. Autotaxin is a ...

    SBIR Phase I 2010 National Science Foundation
  8. Anti-Phospholipid Multiplex For Pathologic Epitopes

    Amount: $248,864.00

    DESCRIPTION (provided by applicant): This project will help delineate the true nature of antigens in antiphospholipid syndrome (APS). Application of this knowledge would accelerate the pace of basic a ...

    SBIR Phase I 2010 Department of Health and Human Services
  9. Aptamer-based Glycomics Tools

    Amount: $277,549.00

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. ...

    STTR Phase II 2010 Department of Health and Human Services
  10. Aptamer-based Glycomics Tools

    Amount: $277,549.00

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. ...

    STTR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government